この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2024/3/291 分で読めます
Over-the-Counter Monograph Drug User Fee Program-Facility Fee Rates for Fiscal Year 2024
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA or the Agency) is announcing the over-the-counter (OTC) monograph drug facility (MDF) fee rates under the OTC monograph drug user fee program (OMUFA) for fiscal year (FY) 2024. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to assess and collect user fees from qualifying manufacturers of OTC monograph drugs and submitters of OTC monograph order requests (OMORs). This notice publishes the OMUFA facility fee rates for FY 2024.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →